TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06708936

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Due to a strategic adjustment, the company has decided to terminate the project.”

The sponsor’s own words in the registry.

Life of this trial

2024202520262027Registered2024-11-25Planned start2026-03-01 (planned)Withdrawn (as of)2026-05-08

Vital statistics

Status
Withdrawn
Phase
Early Phase 1
Sponsor
Kousai Bio Co., Ltd.
Sponsor type
University, hospital or other
Conditions
Clear Cell Renal Cell Carcinoma (ccRCC)
Interventions
KSD-201
Participants
0
Sites
1
Countries
China

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.